Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-{5-[(Z)-(2-imino-4-oxo-1,3-thiazolidin-5-ylidene)methyl]furan-2-yl}-2-(trifluoromethyl)benzenesulfonamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule with the molecular formula C15H10F3N3O4S2 and a molecular weight of approximately 417.4 g/mol[6]. It contains a thiazolidinone core linked to a furan ring and substituted with both sulfonamide and trifluoromethyl groups. The compound is catalogued in chemical databases such as PubChem (CID: 137349068), ChEMBL (CHEMBL233970), and DrugBank (DB07538)[6]. There are no approved medical indications or clinical trials associated with this molecule as of now[8]. Its mechanism of action, biological targets, pharmacological activity, or therapeutic potential have not been established in the literature or major drug databases[8][6].
- Other names
- 4-(5-{[(5Z)-2-imino-4-oxo-1,3-thiazolidin-5-ylidene]methyl}furan-2-y)-2-(trifluoromethyl)benzenesulfonamide4-(5-{(Z)-[(2E)-2-imino–4–oxo–1,3-thiazolidin–5–ylidene]methyl}furan–2–yl)–2-(trifluoromethyl)benzenesulfonamide
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on 4-{5-[(Z)-(2-imino-4-oxo-1,3-thiazolidin-5-ylidene)methyl]furan-2-yl}-2-(trifluoromethyl)benzenesulfonamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4-{5-[(Z)-(2-imino-4-oxo-1,3-thiazolidin-5-ylidene)methyl]furan-2-yl}-2-(trifluoromethyl)benzenesulfonamide.